• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

常见遗传变异与卵巢癌易感性:当前的认识与未来方向。

Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.

机构信息

Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Strangeways Research Laboratory, Cambridge, United Kingdom.

Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina.

出版信息

Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):395-404. doi: 10.1158/1055-9965.EPI-17-0315. Epub 2017 Jun 14.

DOI:10.1158/1055-9965.EPI-17-0315
PMID:28615364
Abstract

In this review, we summarize current progress in the genetic epidemiology of epithelial ovarian cancer (EOC), focusing exclusively on elucidating the role of common germline genetic variation in conferring susceptibility to EOC. We provide an overview of the more than 30 EOC risk loci identified to date by genome-wide association studies (GWAS) and describe the contribution of large-scale, cross-cancer type, custom genotyping projects, such as the OncoArray and the Collaborative Oncological Gene-Environment Study, to locus discovery and replication. We discuss the histotype-specific nature of these EOC risk loci, pleiotropy, or overlapping genetic effects between EOC and other hormone-related cancer types, and the application of findings to polygenic risk prediction for EOC. The second part of the article offers a concise review of primarily laboratory-based studies that have led to the identification of several putative EOC susceptibility genes using common variants at the known EOC risk loci as starting points. More global biological insights emerging from network- and pathway-based analyses of GWAS for EOC susceptibility are also highlighted. Finally, we delve into potential future directions, including the need to identify EOC risk loci in non-European populations and the next generation of GWAS functional studies that are likely to involve genome editing to establish the cell type-specific carcinogenic effects of EOC risk variants

摘要

在这篇综述中,我们总结了上皮性卵巢癌(EOC)遗传流行病学的最新进展,专门阐明了常见种系遗传变异在赋予 EOC 易感性方面的作用。我们概述了迄今为止通过全基因组关联研究(GWAS)确定的 30 多个 EOC 风险位点,并描述了大规模、跨癌症类型的定制基因分型项目(如 OncoArray 和协同肿瘤基因-环境研究)在发现和复制位点方面的贡献。我们讨论了这些 EOC 风险位点的组织类型特异性、多效性或 EOC 与其他激素相关癌症类型之间的重叠遗传效应,以及将发现应用于 EOC 的多基因风险预测。文章的第二部分简要回顾了主要的基于实验室的研究,这些研究使用已知的 EOC 风险位点的常见变体作为起点,确定了几个假定的 EOC 易感性基因。还强调了通过 EOC 易感性的 GWAS 进行网络和途径分析所产生的更全面的生物学见解。最后,我们深入探讨了潜在的未来方向,包括需要在非欧洲人群中识别 EOC 风险位点,以及下一代可能涉及基因组编辑的 GWAS 功能研究,以确定 EOC 风险变异的细胞类型特异性致癌效应。

相似文献

1
Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions.常见遗传变异与卵巢癌易感性:当前的认识与未来方向。
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):395-404. doi: 10.1158/1055-9965.EPI-17-0315. Epub 2017 Jun 14.
2
A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk.一项针对 97898 名女性的转录组关联研究,旨在鉴定上皮性卵巢癌风险的候选易感基因。
Cancer Res. 2018 Sep 15;78(18):5419-5430. doi: 10.1158/0008-5472.CAN-18-0951. Epub 2018 Jul 27.
3
Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.群体水平基因型数据与功能注释的整合揭示了长链非编码RNA在卵巢癌易感位点的过度富集。
Cancer Epidemiol Biomarkers Prev. 2017 Jan;26(1):116-125. doi: 10.1158/1055-9965.EPI-16-0341. Epub 2016 Dec 29.
4
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.综合多组学分析鉴定卵巢癌风险区域的遗传和功能机制。
Am J Hum Genet. 2024 Jun 6;111(6):1061-1083. doi: 10.1016/j.ajhg.2024.04.011. Epub 2024 May 8.
5
Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.常见遗传变异与乳腺癌风险:过去、现在和未来。
Cancer Epidemiol Biomarkers Prev. 2018 Apr;27(4):380-394. doi: 10.1158/1055-9965.EPI-17-1144. Epub 2018 Jan 30.
6
Role of common genetic variants in ovarian cancer susceptibility and outcome: progress to date from the Ovarian Cancer Association Consortium (OCAC).常见遗传变异在卵巢癌易感性和结局中的作用:来自卵巢癌协会联盟(OCAC)的最新进展。
J Intern Med. 2012 Apr;271(4):366-78. doi: 10.1111/j.1365-2796.2011.02509.x.
7
Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women.全基因组关联研究鉴定东亚女性上皮性卵巢癌的易感性位点。
Gynecol Oncol. 2019 May;153(2):343-355. doi: 10.1016/j.ygyno.2019.02.023. Epub 2019 Mar 19.
8
Epithelial ovarian cancer risk: A review of the current genetic landscape.上皮性卵巢癌风险:当前遗传图谱综述。
Clin Genet. 2020 Jan;97(1):54-63. doi: 10.1111/cge.13566. Epub 2019 May 29.
9
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer.鉴定上皮性卵巢癌不同组织学类型的12个新的易感基因座。
Nat Genet. 2017 May;49(5):680-691. doi: 10.1038/ng.3826. Epub 2017 Mar 27.
10
Ovarian Cancer Risk Variants Are Enriched in Histotype-Specific Enhancers and Disrupt Transcription Factor Binding Sites.卵巢癌风险变异在组织亚型特异性增强子中富集,并破坏转录因子结合位点。
Am J Hum Genet. 2020 Oct 1;107(4):622-635. doi: 10.1016/j.ajhg.2020.08.021. Epub 2020 Sep 17.

引用本文的文献

1
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.高级别浆液性卵巢癌中结构多样性的不同轨迹影响患者生存。
Nat Commun. 2025 Jul 1;16(1):5586. doi: 10.1038/s41467-025-60655-y.
2
Characterizing somatic mutations in ovarian cancer germline risk regions.鉴定卵巢癌种系风险区域中的体细胞突变
Commun Biol. 2025 Apr 29;8(1):676. doi: 10.1038/s42003-025-08072-1.
3
Giant Ovarian Tumors in Young Women: Diagnostic and Treatment Challenges-A Report of Two Cases and Narrative Review of the Recent Literature.
年轻女性的巨大卵巢肿瘤:诊断与治疗挑战——两例报告及近期文献综述
J Clin Med. 2025 Feb 13;14(4):1236. doi: 10.3390/jcm14041236.
4
Evaluating Ovarian Cancer Risk-Reducing Salpingectomy Acceptance: A Survey.评估降低卵巢癌风险的输卵管切除术的接受度:一项调查。
Cancer Res Commun. 2025 Jan 1;5(1):187-194. doi: 10.1158/2767-9764.CRC-24-0566.
5
Identification of ubiquitin markers for survival and prognosis of ovarian cancer.卵巢癌生存及预后相关泛素标志物的鉴定
Heliyon. 2024 Sep 7;10(18):e37288. doi: 10.1016/j.heliyon.2024.e37288. eCollection 2024 Sep 30.
6
Rare germline genetic variation in PAX8 transcription factor binding sites and susceptibility to epithelial ovarian cancer.PAX8转录因子结合位点的罕见种系基因变异与上皮性卵巢癌易感性
Am J Epidemiol. 2025 Apr 8;194(4):1023-1031. doi: 10.1093/aje/kwae301.
7
A comprehensive analysis of germline predisposition to early-onset ovarian cancer.对早发性卵巢癌种系易感性的综合分析。
Sci Rep. 2024 Jul 13;14(1):16183. doi: 10.1038/s41598-024-66324-2.
8
Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions.综合多组学分析鉴定卵巢癌风险区域的遗传和功能机制。
Am J Hum Genet. 2024 Jun 6;111(6):1061-1083. doi: 10.1016/j.ajhg.2024.04.011. Epub 2024 May 8.
9
Cis- and trans-eQTL TWASs of breast and ovarian cancer identify more than 100 susceptibility genes in the BCAC and OCAC consortia.乳腺癌和卵巢癌的顺式和反式 eQTL TWASs 在 BCAC 和 OCAC 联盟中鉴定出了 100 多个易感基因。
Am J Hum Genet. 2024 Jun 6;111(6):1084-1099. doi: 10.1016/j.ajhg.2024.04.012. Epub 2024 May 8.
10
Fine-scale mapping of chromosome 9q22.33 identifies candidate causal variant in ovarian cancer.精细定位染色体 9q22.33 确定卵巢癌的候选因果变异。
PeerJ. 2024 Feb 14;12:e16918. doi: 10.7717/peerj.16918. eCollection 2024.